This article summarizes the most significant insider buys and sells from Tuesday, March 4, 2025, for US stocks.
Top Insider Buys:
Owens & Minor Inc . (NYSE: OMI ):
Coliseum Capital, LLC and its affiliates have substantially increased their stake in Owens & Minor Inc. through a series of stock purchases totaling approximately $27.39 million. The transactions, disclosed in a recent SEC filing, occurred over several days with shares acquired at prices ranging from $9.19 to $9.75. The purchases were executed in three separate transactions, with Coliseum Capital acquiring 1,738,511 shares on February 28, followed by an additional 354,901 shares on March 3, and 800,000 shares on March 4. These transactions have collectively increased Coliseum Capital’s holdings in the healthcare logistics company to over 10.6 million shares, representing a significant portion of OMI’s $720 million market capitalization.
Diamondback Energy, Inc. (NASDAQ: FANG ):
Frank D. Tsuru, a director at Diamondback Energy, Inc., has expanded his stake in the company by purchasing 2,000 shares of common stock. The transaction, which took place on February 28, 2025, was executed at an average price of $156.5099 per share, amounting to a total investment of $313,019. Following this acquisition, Tsuru now holds 5,730 shares of the company directly. This move reflects Tsuru’s continued confidence in Diamondback Energy, a leading player in the crude petroleum and natural gas sector, headquartered in Midland, Texas.
Dorchester Minerals, L.P. (NASDAQ: DMLP ):
Bradley J. Ehrman, Chief Executive Officer of Dorchester Minerals, L.P., acquired 3,356 common units of the company. The purchase, executed on March 3, 2025, was made at a price of $29.80 per unit, totaling approximately $100,008. Following this transaction, Ehrman’s indirect holdings, through Quiscalus Ventures, LLC, in which he is the sole member, reached 117,710 units. Additionally, Ehrman holds 15,192 common units in his individual name, IRA, or Keogh Plan.
Goosehead Insurance, Inc. (NASDAQ: GSHD ):
Mark E. Jones Jr., the Chief Financial Officer of Goosehead Insurance, Inc., recently purchased 1,010 shares of the company’s Class A Common Stock at a price of $118.02 per share, totaling approximately $119,200. Following this transaction, Jones now holds a total of 2,342 shares in the company. This purchase reflects the executive’s continued confidence in Goosehead Insurance, a leader in the insurance brokerage industry that has demonstrated strong growth with revenue increasing by 21% in the last twelve months.
Top Insider Sells:
DraftKings North America (NASDAQ: DKNG ):
Matthew Kalish, President of DraftKings North America, recently sold a significant portion of his holdings in the company. According to the latest SEC filing, Kalish sold shares totaling approximately $17.6 million. The sales occurred at prices ranging from $39.77 to $44.05 per share. In addition to these sales, Kalish also engaged in other transactions, including acquiring shares through the exercise of stock options. These acquisitions were valued at around $1.47 million, with prices ranging from $0 to $3.82 per share.
Netflix Inc. (NASDAQ: NFLX ):
Reed Hastings, Executive Chairman of Netflix Inc., has recently engaged in significant stock transactions. On March 3, Hastings sold a substantial amount of Netflix common stock, totaling approximately $29.9 million. The sales were executed at prices ranging from $966.09 to $994.09 per share. In addition to the sales, Hastings acquired 30,485 shares through the exercise of stock options at a price of $93.64 per share, amounting to a total value of approximately $2.85 million.
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ):
Emil D. Kakkis, President and CEO of Ultragenyx Pharmaceutical Inc., recently executed significant stock transactions. On March 3, Kakkis sold 73,434 shares at a weighted average price of $42.10, while on February 28, he sold an additional 25,000 shares at a weighted average price of $42.48. These sales amounted to a total value of approximately $4.15 million. Following these sales, Kakkis retains a substantial number of shares, both directly and indirectly, through the Emil Kakkis and Jenny Soriano Living Trust.
Cigna Group (NYSE: CI ):
David Cordani, Chairman and CEO of Cigna Group, recently completed a significant sale of company stock. On March 3, Cordani sold 26,527 shares at an average price of $308.12 per share, totaling approximately $8.17 million. This transaction was executed under a pre-established Rule 10b5-1 trading plan. In addition to the sale, Cordani engaged in transactions related to tax obligations. On February 28, shares totaling $8.44 million were withheld to cover these tax liabilities.
Ventas, Inc. (NYSE: VTR ):
Debra Cafaro, Chairman and CEO of Ventas, Inc., has recently made significant transactions involving the company’s stock. Cafaro sold shares totaling approximately $2,965,220. The sales occurred in multiple transactions with prices ranging from $69.076 to $71.04 per share. In addition to the sales, Cafaro also exercised stock options, acquiring shares valued at around $2,710,237. The exercise prices for these options ranged from $62.22 to $63.24 per share.
Investors should stay tuned to insider buys and sells as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance. However, it’s important to consider these transactions in the context of broader market trends, company fundamentals, and individual investment goals.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.